SEC Form 4 research

ADIAL PHARMACEUTICALS, INC. insider transactions

Issuer	ADIAL PHARMACEUTICALS, INC.
Tickers	ADIL
Reporting owners	15
Officers and directors	6
Last public filing	2026-09-21

Recent insider disclosures

Available	Trade date	Reporting owners	Code	Shares	Price	Reported value
2026-09-21	2026-09-17	Young Wendy B.	A	25,666	$0	Not reported

Officers and directors in the directory

Gilliland Robertson H. — 1 qualifying
Newman James W. Jr. — 9 qualifying
Stilley William B. III — 5 qualifying
Schuyler Kevin — 8 qualifying
Goodman Tony — 1 qualifying
Johnson Bankole A. — 9 qualifying

Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.